Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Clinical Veterinary Microbiology

Four Independent Molecular Prion Protein Parameters for Discriminating New Cases of C, L, and H Bovine Spongiform Encephalopathy in Cattle

Jan P. M. Langeveld, Jo H. F. Erkens, Ines Rammel, Jorg G. Jacobs, Aart Davidse, Fred G. van Zijderveld, Alex Bossers, Hermann Schildorfer
Jan P. M. Langeveld
1Central Veterinary Institute of Wageningen UR, P.O. Box 65, 8200 AB, Lelystad, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jan.langeveld@wur.nl
Jo H. F. Erkens
1Central Veterinary Institute of Wageningen UR, P.O. Box 65, 8200 AB, Lelystad, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ines Rammel
2Austrian Agency for Health and Food Safety, Institute for Veterinary Disease Control, Robert Koch Gasse 17, 2340 Mödling, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorg G. Jacobs
1Central Veterinary Institute of Wageningen UR, P.O. Box 65, 8200 AB, Lelystad, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aart Davidse
1Central Veterinary Institute of Wageningen UR, P.O. Box 65, 8200 AB, Lelystad, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fred G. van Zijderveld
1Central Veterinary Institute of Wageningen UR, P.O. Box 65, 8200 AB, Lelystad, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Bossers
1Central Veterinary Institute of Wageningen UR, P.O. Box 65, 8200 AB, Lelystad, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hermann Schildorfer
2Austrian Agency for Health and Food Safety, Institute for Veterinary Disease Control, Robert Koch Gasse 17, 2340 Mödling, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.01102-11
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

In anticipation of the emergence of more variants of bovine spongiform encephalopathy (BSE), a semiquantitative display of the following four independent molecular diagnostic prion parameters was designed: N terminus, proteinase K (PK) resistance, glycoprofile, and mixed population. One H BSE case, three L BSE cases, six C BSE cases, and one unusual classical BSE (C BSE) case are reported.

TEXT

The epidemic of bovine spongiform encephalopathy (BSE) in the United Kingdom and other countries, with the subsequent emergence of a variant form of Creutzfeldt-Jakob disease in humans, had urged the European Union (EU) in 2001 to take costly measures by active monitoring cattle for BSE and banning the recycling of mammalian offal proteins into feed (8). Eight years later, due to the effectiveness of the control measures taken, new BSE cases rarely occur.

It has become evident that atypical BSE types exist in cattle (2, 5). These variants seem to be sporadic, and all occurred in animals 8 years and older (2–7, 10, 13–15, 17–19, 1–23), except one isolated 2-year-old case (24). BSE cases are now classified into classical BSE (C BSE), L BSE, and H BSE based on Western blot (WB) analysis of PrPres, the proteinase K (PK)-resistant fragment of the disease-associated prion protein (PrP) isoform PrPSc (15). It must be anticipated that with continuing active surveillance, a majority of cases will appear as natural sporadic forms (2). Confirmation of such cases requires effective criteria.

In this study, the molecular properties of brain stem PrPres in eight Austrian and three recently reported BSE cases in the Netherlands (Table 1) were investigated by WB analysis with PrP-specific monoclonal antibodies (MAbs) 12B2, P4, L42, and SAF84. These are specific for bovine PrP epitopes 101WGQGG105, 101WGQGGSH107, 156YEDRYY161, and 174YRPVDQY180, respectively (1, 2, 9, 11, 12, 14, 20). Two WB detection methods were applied. The first method used was based on enzymatic chemiluminescent enhancement procedures followed by photographic film exposure (15), and the second WB method used was a recently developed multiplex fluorophore labeling method and was used here for glycoprofile estimations (16). This multiplex technique provided a reliable tool for glycotyping for two reasons: the absence of substrate spreading from the protein banding regions and the area of measurement is exactly the same when comparing the PrPres glycoprofiles for different MAbs. Relative antibody staining intensities between blots, between two lanes, or for PrPres glycoform estimations were performed as described previously (15, 16).

View this table:
  • View inline
  • View popup
Table 1.

Details of Austrian and Dutch BSE cases until March 2011a

Western blot PrPres patterns obtained for the samples were similar to those reported for bovine C, L, and H BSE cases (15, 16). These patterns of MAb binding were transformed semiquantitatively as ratios of staining intensities reflecting four independent PrPres aspects in two graphs (Fig. 1a and b). The first aspect concerned the N-terminal aspect, represented by the 12B2 epitope. Most BSE samples had small amounts of this epitope (12B2/L42 ratio of <0.4), typical for C and L BSE. Sample AU08 exhibited relatively high N terminus epitope retention, as did the H BSE reference sample (Fig. 1a, vertical axis). In addition, both AU08 and the reference H sample contained an additional 7-kDa band with antibodies 12B2 and L42 (Fig. 2) (15). One Austrian case (AU05) was special since it reacted with substantial 12B2 intensity compared to MAb L42 (Fig. 2, lanes 1). Moreover, when probed with N terminus-specific MAb P4 (epitope WGQGGSH, which carries the same N-terminal amino acid as the epitope of 12B2), there was unusually high binding of this antibody to AU05, about equal to that of MAb 12B2, not seen in any of the N terminus epitope-carrying H BSE cases (Fig. 2, compare lanes 1 and 2) or in our previously studied C BSE cases (15, 16).

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Combined graphical presentations of four independent discriminatory PrPres parameters for BSE isolate typing. (a) The vertical axis reflects the abundance of the N-terminal epitope of MAb 12B2 relative to the core epitope of MAb L42. On the horizontal axis, the ratio of monoglycosyl to diglycosyl forms (M/D) as probed with MAb L42 reflects a glycoprofile property of the triple-banded PrPres pattern. (b) The vertical axis reflects the resistance to PK, measured as the L42 binding ratio between samples digested at pH 8 and pH 6.5. The horizontal axis with the SAF84/L42 ratio represents another glycoprofile aspect—values of >1.25 point to the existence of two populations of PrPres triple bands in one sample (15). (a and b) By dividing the graphs each into four sectors, 1 to 4 (following the hands of the clock starting from the bottom left sector), the isolate types studied can be assigned to the following categories for C, L, and H BSE: A1B2, A4B1, and A2B4, respectively. The single classical scrapie case fits into category A2B2. The AU05 isolate is considered an exceptional C BSE case due to its N terminus aspect and, thus, having an intermediate behavior between the A1B2 and A2B2 categories.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Inspection of N-terminal epitope abundance with MAbs P4 and 12B2 relative to the PrP core L42 epitope. Lane 1, AU05; lane 2, reference H BSE; lane 3, C-type reference; lane 4, AU04; lane 5, AU02; lane 6, classical scrapie. Applied tissue equivalent (milligrams of tissue per lane) (TE) for lanes 1 to 4, 0.5 mg; for lane 5, 2.5 mg; for lane 6, 0.25 mg. The positions of the D, M, and N triple glycoprofile bands are indicated. The region for glycoprofile estimation is indicated with a double-headed arrow. The migration positions of three molecular mass standards are indicated in kDa. The M position coincides with the referred migration at 22 kDa (Fig. 1). A 7-kDa fragment is observed in H BSE samples (arrow).

A further tool for diagnosis was the analysis of resistance to PK digestion by comparing samples digested at pH 6.5 with 50 μg/ml PK and at pH 8 with 500 μg/ml PK (Fig. 1b, vertical axis). Samples AU01 to AU05 and NL86 and NL87 appeared equally resistant to PK as did the reference C BSE samples, reflected by pH 8/pH 6.5 ratios of between 0.7 and 1. Samples AU06, AU07, AU08, and NL88 compared to the poorly PK-resistant L and H BSE reference samples.

PrPres is usually characterized by a triple banding pattern that is composed of nonglycosylated (N), monoglycosylated (M), and diglycosylated (D) PrP fragments having molecular masses around 18, 22, and 28 kDa, respectively (Fig. 2). The sum of the antibody binding values for N+M+D fragments in this region was set at 1, and their fragment fractions were used for ratio calculations shown in Fig. 1a and b. When tested with MAb L42, a low M-to-D fragment ratio (≤0.3) was observed for the samples AU01, AU02, AU03, AU04, AU05, NL73, NL74, NL86, and NL87 as well as for the two reference C BSE samples (Fig. 1a, horizontal axis). Samples AU06, AU07, NL88, and reference L BSE exhibited a higher fraction of M-PrPres (M/D fragment ratio = ±1). Compared to the C and L BSE-like cases, the AU08 sample and the reference H BSE M/D fragment values were intermediate (M/D fragment ratio = ±0.5).

As a fourth criterion, glycoprofile results between those obtained with MAbs L42 and SAF84 were compared, and they were rather similar for most samples, except for case AU08 and the reference H BSE sample. This could be illustrated in the plot by the binding ratio between SAF84 and L42 at the M position (Fig. 1b, horizontal axis). This so-called dualistic behavior was previously shown to be a result of the existence of a mixture of two PrPres populations in H BSE isolates (1, 15).

When dissecting the graphs shown in Fig. 1 into four sectors, 16 categories can be constructed. The samples shown in our study fit into four of these: A1B2, A2B2, A4B1, and A2B4 for C BSE, AU05 (and scrapie), L BSE, and H BSE, respectively (Table 1). The most recent cases in Austria and the Netherlands were L type (AU06, AU07, NL88) and H type (AU08), while AU05 behaved as a C BSE case with a peculiar characteristic of an enhanced presence of the N-terminal 101WGQGG105 PrP sequence and unusually strong MAb P4 binding for bovine PrP. Unfortunately, no more AU05 tissue is available for strain typing, and the tissue was subject to strong autolysis, which might have influenced the outcome.

Considering the old ages of the BSE cases detected, it would be best to maintain BSE surveillance of cattle in the age cohort of at least 8 years and older.

ACKNOWLEDGMENTS

We are grateful to Anne Buschmann (FLI) for providing the sample of the second Austrian BSE case and reference samples of atypical BSE cases from preceding studies and to Michaela Mannsfeldner for performing the preceding studies.

These investigations were supported by the Austrian Agency for Health and Food Safety (AGES) and the Dutch Ministry of Economic Affairs, Agriculture and Innovation, project WOT-01-002-001.01. The multiplex WB was developed under project SE1700/CSA 7335 from the Department for Environment, Food and Rural Affairs (Defra; United Kingdom).

FOOTNOTES

    • Received 31 May 2011.
    • Accepted 2 June 2011.
    • Accepted manuscript posted online 15 June 2011.
  • Copyright © 2011, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Biacabe A. G.,
    2. Jacobs J. G.,
    3. Bencsik A.,
    4. Langeveld J. P.,
    5. Baron T. G.
    . 2007. H-type bovine spongiform encephalopathy: complex molecular features and similarities with human prion diseases. Prion 1:61–68.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Biacabe A. G.,
    2. Laplanche J. L.,
    3. Ryder S.,
    4. Baron T.
    . 2004. Distinct molecular phenotypes in bovine prion diseases. EMBO Rep. 5:110–115.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Biacabe A. G.,
    2. Morignat E.,
    3. Vulin J.,
    4. Calavas D.,
    5. Baron T. G.
    . 2008. Atypical bovine spongiform encephalopathies, France, 2001–2007. Emerg. Infect. Dis. 14:298–300.
    OpenUrl
  4. 4.↵
    1. Buschmann A.,
    2. et al
    . 2006. Atypical BSE in Germany—proof of transmissibility and biochemical characterization. Vet. Microbiol. 117:103–116.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Casalone C.,
    2. et al
    . 2004. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. U. S. A. 101:3065–3070.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Dobly A.,
    2. et al
    . 2010. No H- and L-type cases in Belgium in cattle diagnosed with bovine spongiform encephalopathy (1999–2008) aging seven years and older. BMC Vet. Res. 6:26.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Dudas S.,
    2. et al
    . 2010. Molecular, biochemical and genetic characteristics of BSE in Canada. PLoS One 5:e10638.
    OpenUrlCrossRefPubMed
  8. 8.↵
    European Union. 2001. Regulation (EC) no. 999/2001 of the European parliament and of the council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies. Off. J. Eur. Communities L147:1–40.
    OpenUrl
  9. 9.↵
    1. Feraudet C.,
    2. et al
    . 2005. Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J. Biol. Chem. 280:11247–11258.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Gavier-Widen D.,
    2. et al
    . 2008. Bovine spongiform encephalopathy in Sweden: an H-type variant. J. Vet. Diagn. Invest. 20:2–10.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Geysen H. M.,
    2. Meloen R. H.,
    3. Barteling S. J.
    . 1984. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc. Natl. Acad. Sci. U. S. A. 81:3998–4002.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Goldmann W.,
    2. Hunter N.,
    3. Martin T.,
    4. Dawson M.,
    5. Hope J.
    . 1991. Different forms of the bovine PrP gene have five or six copies of a short, G-C-rich element within the protein-coding exon. J. Gen. Virol. 72(Pt. 1):201–204.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Hagiwara K.,
    2. et al
    . 2007. Accumulation of mono-glycosylated form-rich, plaque-forming PrPSc in the second atypical bovine spongiform encephalopathy case in Japan. Jpn. J. Infect. Dis. 60:305–308.
    OpenUrl
  14. 14.↵
    1. Harmeyer S.,
    2. Pfaff E.,
    3. Groschup M. H.
    . 1998. Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants. J. Gen. Virol. 79(Pt. 4):937–945.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Jacobs J. G.,
    2. et al
    . 2007. Molecular discrimination of atypical bovine spongiform encephalopathy strains from a geographical region spanning a wide area in Europe. J. Clin. Microbiol. 45:1821–1829.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Jacobs J. G.,
    2. et al
    . 2011. Differentiation of ruminant transmissible spongiform encephalopathy isolate types, including bovine spongiform encephalopathy and CH1641 scrapie. J. Gen. Virol. 92:222–232.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Polak M. P.,
    2. Zmudzinski J. F.,
    3. Jacobs J. G.,
    4. Langeveld J. P.
    . 2008. Atypical status of bovine spongiform encephalopathy in Poland: a molecular typing study. Arch. Virol. 153:69–79.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Richt J. A.,
    2. et al
    . 2007. Identification and characterization of two bovine spongiform encephalopathy cases diagnosed in the United States. J. Vet. Diagn. Invest. 19:142–154.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Seuberlich T.,
    2. et al
    . 2006. Spongiform encephalopathy in a miniature zebu. Emerg. Infect. Dis. 12:1950–1953.
    OpenUrl
  20. 20.↵
    1. Slootstra J. W.,
    2. Puijk W. C.,
    3. Ligtvoet G. J.,
    4. Langeveld J. P.,
    5. Meloen R. H.
    . 1996. Structural aspects of antibody-antigen interaction revealed through small random peptide libraries. Mol. Divers. 1:87–96.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. Stack M.,
    2. et al
    . 2009. Two unusual bovine spongiform encephalopathy cases detected in Great Britain. Zoonoses Public Health 56:376–383.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Stack M. J.,
    2. et al
    . 2009. Third atypical BSE case in Great Britain with an H-type molecular profile. Vet. Rec. 165:605–606.
    OpenUrlFREE Full Text
  23. 23.↵
    1. Vidal E.,
    2. et al
    . 2007. Molecular profiling and comparison of field transmissible spongiform encephalopathy cases diagnosed in Catalunya. Vet. J. 174:196–199.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Yamakawa Y.,
    2. et al
    . 2003. Atypical proteinase K-resistant prion protein (PrPres) observed in an apparently healthy 23-month-old Holstein steer. Jpn. J. Infect. Dis. 56:221–222.
    OpenUrl
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Four Independent Molecular Prion Protein Parameters for Discriminating New Cases of C, L, and H Bovine Spongiform Encephalopathy in Cattle
Jan P. M. Langeveld, Jo H. F. Erkens, Ines Rammel, Jorg G. Jacobs, Aart Davidse, Fred G. van Zijderveld, Alex Bossers, Hermann Schildorfer
Journal of Clinical Microbiology Jul 2011, 49 (8) 3026-3028; DOI: 10.1128/JCM.01102-11

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Four Independent Molecular Prion Protein Parameters for Discriminating New Cases of C, L, and H Bovine Spongiform Encephalopathy in Cattle
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Four Independent Molecular Prion Protein Parameters for Discriminating New Cases of C, L, and H Bovine Spongiform Encephalopathy in Cattle
Jan P. M. Langeveld, Jo H. F. Erkens, Ines Rammel, Jorg G. Jacobs, Aart Davidse, Fred G. van Zijderveld, Alex Bossers, Hermann Schildorfer
Journal of Clinical Microbiology Jul 2011, 49 (8) 3026-3028; DOI: 10.1128/JCM.01102-11
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • TEXT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X